- Home
- JANX vs TNC Comparison
JANX vs TNC Comparison
Compare JANX & TNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- TNC
- Stock Information
- Founded
- JANX 2017
- TNC 1870
- Country
- JANX United States
- TNC United States
- Employees
- JANX N/A
- TNC N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- TNC Industrial Machinery/Components
- Sector
- JANX Health Care
- TNC Industrials
- Exchange
- JANX Nasdaq
- TNC Nasdaq
- Market Cap
- JANX 1.6B
- TNC 1.4B
- IPO Year
- JANX 2021
- TNC N/A
- Fundamental
- Price
- JANX $23.60
- TNC $74.27
- Analyst Decision
- JANX Strong Buy
- TNC Strong Buy
- Analyst Count
- JANX 7
- TNC 1
- Target Price
- JANX $94.29
- TNC $125.00
- AVG Volume (30 Days)
- JANX 808.2K
- TNC 124.3K
- Earning Date
- JANX 08-06-2025
- TNC 08-07-2025
- Dividend Yield
- JANX N/A
- TNC 1.58%
- EPS Growth
- JANX N/A
- TNC N/A
- EPS
- JANX N/A
- TNC 3.58
- Revenue
- JANX $9,336,000.00
- TNC $1,265,700,000.00
- Revenue This Year
- JANX N/A
- TNC N/A
- Revenue Next Year
- JANX $1,470.82
- TNC $4.25
- P/E Ratio
- JANX N/A
- TNC $20.96
- Revenue Growth
- JANX 28.12
- TNC 1.35
- 52 Week Low
- JANX $22.48
- TNC $67.32
- 52 Week High
- JANX $71.71
- TNC $110.45
- Technical
- Relative Strength Index (RSI)
- JANX 41.60
- TNC 48.68
- Support Level
- JANX $24.45
- TNC $73.69
- Resistance Level
- JANX $27.28
- TNC $76.09
- Average True Range (ATR)
- JANX 1.35
- TNC 1.60
- MACD
- JANX -0.09
- TNC -0.04
- Stochastic Oscillator
- JANX 22.20
- TNC 44.74
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About TNC Tennant Company
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.